RDG README File Template --- General --- Version: 0.1 (2022-10-04)   This README file was generated on [2023-07-25] by [Allix-Béguec Caroline]. Last updated: [2023-10-24].   # GENERAL INFORMATION   ## Dataset title: Long-term effectiveness of a stent-less strategy in patients with coronary artery disease: 3-year follow-up of a prospective all-comers observational study (SCRAP3y)   ## DOI: 10.5281/zenodo.8182420   ## Contact email: recherche.clinique@ght-atlantique17.fr     # METHODOLOGICAL INFORMATION   ## Environmental/experimental conditions: Cohort study   ## Description of sources and methods used to collect and generate data: Data were collected from medical records and follow-up at one and three years   ## Methods for processing the data: *CardioReport has generated the initial database. *A code was used for each patient consisting of the first letter of the surname and first name, followed by a number. *Follow-up data were collected on Excel by a study site coordinator. ## Quality -assurance procedures performed on the data: *Inclusion criteria, primary and secondary outcomes were monitored by clinical research assistants. *In case of inconsistencies, queries were sent to the study site coordinator for confirmation or correction. *Before closing the database, outliers were detected by the statistician and queries were sent to the study site coordinator for confirmation or correction.     # DATA & FILE OVERVIEW   ## File naming convention: date_file content_version.extension     # DATA-SPECIFIC INFORMATION FOR: 230203_Data_V01.csv   ## Variable/Column List: For each variable or column name : -- full “human readable” name of the variable, -- description of the variable, -- unit of measurement if applicable, -- decimal separator *i.e.* comma or point if applicable -- allowed values : list of values or range, or domain -- format if applicable, e.g. date> * -- ID Patient -- Patient unique key -- -- -- -- Text * -- Sex -- -- -- -- 1:female ; 2:male -- Option * -- Age -- -- year -- -- -- Number * -- BMI -- Body mass index -- kg/m2 -- point -- -- Number * -- Family history of CAD -- Family history of coronary artery disease -- -- -- 0:no history ; 1:history -- Option * -- Diabetes -- -- -- -- 0:no diabetes ; 1:diabetes -- Option * -- Hypertension -- Hypertension arterial -- -- -- 0:no hypertension ; 1:hypertension -- Option * -- Smoking -- Tobacco use -- -- -- 0:non-tobacco user ; 1:tobacco user ; 2:ex-tobacco user -- Option * -- History of revascularization -- History of coronary revascularization -- -- -- 0:no history ; 1:history -- Option * -- Bypass -- History of arterial bypass operation -- -- -- 0:no history ; 1:history -- Option * -- History of myocardial infarction -- -- -- -- 0:no history ; 1:history -- Option * -- History of stroke -- -- -- -- 0:no history ; 1:history -- Option * -- Peripheral arterial occlusive disease -- History of peripheral arterial occlusive disease -- -- -- 0:no history ; 1:history -- Option * -- LVEF -- Left ventricular ejection fraction -- -- -- 1:≥ 50% ; 2:35-50% ; 3:≤ 35% -- Option * -- Indication -- Type of cardiac disorder -- -- -- 1:STEMI ; 2: Non STEMI ; 3:chronic coronary syndrom -- Option * -- Angioplasty strategy -- -- -- -- 1: conventional-DES; 2: BO-DES; 3: DCB only -- Option * -- One year follow-up -- Type of contact with the patients -- -- -- 0:Lost to follow-up ; 1:phone ; 2:in-hospital ; 3:consultation ; 4:deceased -- Option * -- Lost to follow-up reason -- -- -- -- -- Text * -- ASA -- acetyl salicilic acid -- -- -- 0:no ; 1:yes -- Option * -- APA -- anti-platelet agent -- -- -- 0:no ; 1:yes -- Option * -- ACO -- anticoagulant -- -- -- 0:no ; 1:yes -- Option * -- MACE -- Major adverse cardiac event -- -- -- 0:no ; 1:yes -- Option * -- Type of MACE -- -- -- -- 0:no event ; 1:Coronary revascularization ; 2:non-fatal stroke ; 3:non-fatal myocardial infarction ; 4:death (all causes) -- Option * -- Comment -- -- -- -- -- Text * -- 3-year follow-up -- Type of contact with the patients -- -- -- 0:Lost to follow-up ; 1:phone ; 2:in-hospital ; 3:consultation ; 4:deceased; 5:consent withdrawal -- Option * -- MACE 3-year follow-up -- Major adverse cardiac event that happened between 1 and 3 years after the procedure -- -- -- 0:no ; 1:yes -- Option * -- Type of MACE 1 -- -- -- -- 0:no event ; 1:Coronary revascularization ; 2:non-fatal stroke ; 3:non-fatal myocardial infarction ; 4:death (all causes) -- Option * -- Type of MACE 2 -- -- -- -- 0:no event ; 1:Coronary revascularization ; 2:non-fatal stroke ; 3:non-fatal myocardial infarction ; 4:death (all causes) -- Option * -- N MACE -- Number of MACE -- -- -- -- Number * -- ISR/TLR -- lesion revascularization -- -- -- 1:intra-stent revascularization; 2:target lesion revascularization after DCB; 3:ISR+TLR -- Option * -- ASA at 3-year follow-up -- acetyl salicilic acid -- -- -- 0:no ; 1:yes -- Option * -- APA at 3-year follow-up -- anti-platelet agent -- -- -- 0:no ; 1:yes -- Option * -- ACO at 3-year follow-up -- anticoagulant -- -- -- 0:no ; 1:yes -- Option * -- Covid-19 -- confirmed by PCR within the 3-year follow-up -- -- -- 0:no ; 1:yes -- Option * -- Time to 1-year MACE -- -- months -- -- -- Number * -- Time to 3-year MACE 1 -- -- months -- -- -- Number * -- Time to 3-year MACE 2 -- -- months -- -- -- Number * -- Time to last follow-up -- -- months -- -- -- Number ## Missing data codes: Blank for missing data NA for non applicable